Acne vulgaris: navigating the NICE recommendations for specialist referral, patient expectations, and the isotretinoin product licence.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad025
Abstract: Oral isotretinoin is a highly effective drug for severe acne but with ongoing serious safety concerns, and we are cautiously reminded by the Medicines and Healthcare products Regulatory Authority (MHRA) to prescribe this drug within… read more here.
Keywords: licence; product licence; nice recommendations; patient expectations ... See more keywords